Relapse rates of inflammatory bowel disease patients in deep and clinical remission after discontinuing anti-tumor necrosis factor alpha therapy / Hlavaty T. ... [et al.]. Bratislavské lekárske listy Vol. 117, no. 4 (2016), s. 205-211